Private Equity

Updated:

Juren Capital

Zhejiang Juren Capital Management Co., also known as Juren Capital, provides Private Equity investment, Mergers & Acquisition, Strategic Consulting, and...

Juren Capital

Zhejiang Juren Capital Management Co., also known as Juren Capital, provides Private Equity investment, Mergers & Acquisition, Strategic Consulting, and Financial Advisement services. The firm has made 14 investments, including a Series B investment in Aomo Pharmaceutical on August 25, 2021. Juren Capital has facilitated 4 portfolio exits, with the most recent being Microtech Medical on October 19, 2021.

General information

Firm type

Private Equity

Year founded

2013

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Hangzhou

Corporate office

Hangzhou, China

Frequently asked questions

What investment stages does Juren Capital target?

The firm operates across the full Chinese venture and growth lifecycle, from seed and start-up rounds through expansion and late-stage growth to pre-IPO placements and PIPE transactions. This multi-stage mandate means the firm can follow portfolio companies from early formation through near-public liquidity events without capping its participation at any single stage boundary.

Does Juren Capital invest through offshore or purely onshore structures?

Based on its Hangzhou headquarters and available public record, Juren Capital operates within China's onshore renminbi fund ecosystem. There is no indication of a Cayman or Hong Kong parallel fund vehicle, which would limit the participation of foreign institutional LPs who typically invest through offshore fund structures. The firm's capital base likely draws from domestic high-net-worth investors, family offices, and local government guidance funds.

How does Hangzhou as a location shape Juren Capital's deal flow?

Hangzhou hosts Alibaba Group's global headquarters, creating a dense ecosystem of technology talent, startup spinouts, and supply-chain financing opportunities across Zhejiang province. For a domestic private equity firm like Juren Capital, proximity to that entrepreneurial density, combined with Hangzhou's cluster of family offices and asset managers, provides access to proprietary or semi-proprietary deal flow in China's eastern technology corridor.

Is Juren Capital structured as a venture firm or a growth-equity manager?

Juren Capital is structured as a catch-all private equity platform rather than a pure venture or growth-equity manager. Its mandate encompasses seed and venture capital, expansion and late-stage growth, pre-IPO placements, and PIPE transactions. This structure consolidates deployment under a single decision-making framework, distinguishing it from firms that operate separate venture and growth funds with independent teams.

Who runs investment decisions at Juren Capital?

Publicly available information does not name specific investment committee members or managing partners at Juren Capital. This level of operational opacity is common among private Chinese asset managers, where personnel details and governance structures are rarely disclosed beyond regulatory filings or direct LP relationships.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Hangzhou Private Equity profiles